Impact of a European Training Program for Robotic Liver Surgery (LIVEROBOT)

NCT05723705 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3600

Last updated 2023-03-27

No results posted yet for this study

Summary

LIVEROBOT is a collaboration of high-volume liver surgical centers in Europe (≥60 liver resections per year), supported by the European-African Hepato-Pancreato-Biliary Association Education Committee (E-AHPBA), and the European Registry of Minimally Invasive Liver Surgery (E-MILS) aiming to support the step-up implementation and safety of advanced surgical expertise of robotic liver surgery (RLS) on a European basis. The LIVEROBOT training program aims to promote the safe implementation of RLS throughout Europe. The data from all patients operated on during a surgeons' participation in the training program will be prospectively gathered allowing for learning curve and outcome analyses.

Conditions

Interventions

OTHER

European Multicentre Training Program for Robotic Liver Surgery

LIVEROBOT is a pan-european multicentre training program for robotic liver surgery involving simulation training, a procedure video-library, on and off-site proctoring, and video-assessment.

Sponsors & Collaborators

  • UMC Utrecht

    collaborator OTHER
  • General Hospital Groeninge

    collaborator OTHER
  • Fondazione Poliambulanza Istituto Ospedaliero

    collaborator OTHER
  • Intuitive Surgical

    collaborator INDUSTRY
  • Amsterdam UMC, location VUmc

    lead OTHER

Principal Investigators

  • Rutger-Jan Swijnenburg, MD PhD · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

  • Jeroen Hagendoorn, MD PhD · UMC Utrecht

  • Mathieu d'Hondt, MD PhD · AZ Groeninge

  • Mohammed Abu Hilal, MD PhD · Poliambulanza Foundation Hospital Brescia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-30
Primary Completion
2025-12-31
Completion
2025-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05723705 on ClinicalTrials.gov